Data on Umbralisib in Relapsed/Refractory Lymphoma

Lori A. Leslie, MD, Hematologist-Oncologist, Lymphoma Department, John Theurer Cancer Center, Hackensack Meridian Health explains the results of the umbralisib phase II study involving patients with r... Author: obr Added: 06/27/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts